Skip to main content
Caplight Logo









3H Bio

3H Bio

Private
South KoreaHealthcare & Life Scienceshttps://threehbio.com/layout/eng/home.php?go=main

Company Overview

3H Bio operates in Healthcare & Life Sciences and is based in South Korea. It was founded in 2019.

3H Bio is a biotechnology company that develops peptide-based immunotherapies and first-in-class drugs for metabolic and cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

3H Bio Comparables

Compare 3H Bio with similar companies based on industry and business-model similarity.

3H Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
D&D Pharmatech
72%
AFFiRiS AG
70%
G2GBIO
64%
Book a demo to see all comparables

For institutional investors. Book with your work email.

3H Bio Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for 3H Bio. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

3H Bio Investors

Notable investors and investment history

3H Bio Filings

Explore SEC and related filing metadata, where available.

3H Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about 3H Bio's valuation, stock price, and market status.

Is 3H Bio a public or private company?

3H Bio is a private company.

What is the current stock price of 3H Bio?

3H Bio is a private company with no public stock price. Caplight tracks 3H Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is 3H Bio worth (valuation)?

Valuation information for 3H Bio is not publicly available.

Can I buy 3H Bio stock?

3H Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 3H Bio's last funding round?

Funding round information for 3H Bio is not publicly available.

Who are the main investors in 3H Bio?

Key investors in 3H Bio include Chungbuk Center for Creative Economy & Innovation, BNK Venture Capital, Honest Ventures, IPS Ventures.

Will 3H Bio IPO soon?

No public IPO plans have been announced for 3H Bio.

How can I track 3H Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 3H Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Year Founded2019
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?